Arginase 2 deficiency results in spontaneous steatohepatitis: a novel link between innate immune activation and hepatic de novo lipogenesis.

[1]  Lynne Pearce,et al.  Non-alcoholic fatty liver disease. , 2016, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[2]  J. Browning,et al.  Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. , 2014, Gastroenterology.

[3]  A. Wree,et al.  NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice , 2014, Hepatology.

[4]  A. Wree,et al.  From NAFLD to NASH to cirrhosis—new insights into disease mechanisms , 2013, Nature Reviews Gastroenterology &Hepatology.

[5]  A. Bast,et al.  The role of oxidative stress in non-alcoholic steatohepatitis. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[6]  V. Ratziu,et al.  An overview of nonalcoholic steatohepatitis: past, present and future directions. , 2010, Journal of gastrointestinal and liver diseases : JGLD.

[7]  H. Tilg,et al.  Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis , 2010, Hepatology.

[8]  F. Foufelle,et al.  Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP‐1c , 2010, Diabetes, obesity & metabolism.

[9]  S. Caldwell,et al.  The Natural History of Non-Alcoholic Fatty Liver Disease , 2010, Digestive Diseases.

[10]  S. Klein,et al.  Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications , 2010, Hepatology.

[11]  Hirokazu Takahashi,et al.  Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model. , 2010, Alcoholism, clinical and experimental research.

[12]  N. Van Rooijen,et al.  Liposomes for specific depletion of macrophages from organs and tissues. , 2010, Methods in molecular biology.

[13]  S. Mohanty,et al.  Nonalcoholic Fatty Liver Disease: A Review and Update , 2010, Digestive Diseases and Sciences.

[14]  P. Schauer,et al.  Adipocyte Apoptosis, a Link between Obesity, Insulin Resistance, and Hepatic Steatosis* , 2009, The Journal of Biological Chemistry.

[15]  M. Munder.  Arginase: an emerging key player in the mammalian immune system , 2009, British journal of pharmacology.

[16]  G. Baffy.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view. , 2009, Journal of hepatology.

[17]  E. Bugianesi,et al.  The gut‐liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance? , 2009, Hepatology.

[18]  G. La Torre,et al.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.

[19]  A. Feldstein,et al.  Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive , 2008, Seminars in liver disease.

[20]  S. Bischoff,et al.  Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. , 2008, The Journal of nutrition.

[21]  P. Tontonoz,et al.  Arginase I induction by modified lipoproteins in macrophages: a peroxisome proliferator-activated receptor-gamma/delta-mediated effect that links lipid metabolism and immunity. , 2008, Molecular endocrinology.

[22]  M. Torbenson,et al.  Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration , 2008, Hepatology.

[23]  M. Mori.  Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling. , 2007, The Journal of nutrition.

[24]  Jeffrey B. Schwimmer,et al.  Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.

[25]  M. Holmqvist,et al.  Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.

[26]  N. Maeda,et al.  Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates. , 2006, Journal of hepatology.

[27]  A. Feldstein,et al.  Nonalcoholic fatty liver disease in the pediatric population: a review , 2005, Current opinion in pediatrics.

[28]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[29]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[30]  P. Angulo,et al.  Nonalcoholic fatty liver disease. , 2002, Revista de gastroenterologia de Mexico.

[31]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[32]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Malekzadeh,et al.  Obesity and non-alcoholic fatty liver disease , 2004 .

[34]  H. Zoghbi,et al.  Generation of a Mouse Model for Arginase II Deficiency by Targeted Disruption of the Arginase II Gene , 2001, Molecular and Cellular Biology.

[35]  A. Keshavarzian,et al.  Exacerbation of alcoholic liver injury by enteral endotoxin in rats , 2000, Hepatology.

[36]  T. Gotoh,et al.  Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide. , 1999, American journal of physiology. Endocrinology and metabolism.

[37]  Z. Younossi,et al.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.

[38]  T. Billiar,et al.  Inducible nitric oxide synthase in the liver: regulation and function. , 1998, Biochemistry. Biokhimiia.

[39]  J. Albina,et al.  Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[40]  M. Clemens,et al.  Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Takiguchi,et al.  Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage‐like cell line , 1996, FEBS letters.

[42]  T. K. van den Berg,et al.  Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. , 1996, Journal of immunological methods.

[43]  W. Grody,et al.  Comparative properties of arginases. , 1996, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.